Rachel Schindler

3.7k total citations · 1 hit paper
49 papers, 2.2k citations indexed

About

Rachel Schindler is a scholar working on Psychiatry and Mental health, Pharmacology and Physiology. According to data from OpenAlex, Rachel Schindler has authored 49 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 11 papers in Physiology. Recurrent topics in Rachel Schindler's work include Dementia and Cognitive Impairment Research (24 papers), Alzheimer's disease research and treatments (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Rachel Schindler is often cited by papers focused on Dementia and Cognitive Impairment Research (24 papers), Alzheimer's disease research and treatments (9 papers) and Cholinesterase and Neurodegenerative Diseases (8 papers). Rachel Schindler collaborates with scholars based in United States, Canada and United Kingdom. Rachel Schindler's co-authors include Howard Feldman, Todd E. Feinberg, Sandra E. Black, Rachelle S. Doody, Roy Jones, María C. Carrillo, Elias Schwam, Stephen Salloway, Michael Grundman and Eric Siemers and has published in prestigious journals such as Neurology, Stroke and International Journal of Environmental Research and Public Health.

In The Last Decade

Rachel Schindler

49 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup

2011 554 citations Reisa A. Sperling, Clifford R. Jack et al. Alzheimer s & Dementia profile →

Peers

Countries citing papers authored by Rachel Schindler

Since Specialization

Citations

This map shows the geographic impact of Rachel Schindler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Schindler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Schindler more than expected).

Fields of papers citing papers by Rachel Schindler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Schindler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Schindler. The network helps show where Rachel Schindler may publish in the future.

Co-authorship network of co-authors of Rachel Schindler

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Schindler. A scholar is included among the top collaborators of Rachel Schindler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Schindler. Rachel Schindler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Weight-Based Teasing and Metabolic Syndrome Components among Adolescent Military Dependents at Risk for Adult Obesity 2021 ·Childhood Obesity ·(unknown), Natasha A. Schvey, Lisa M. Shank, (unknown), Jason M. Lavender, (unknown), (unknown), Rachel Schindler, Tracy Sbrocco, (unknown), Mark Stephens, Mark C. Haigney, David A. Klein, Jeffrey D. Quinlan, Jack A. Yanovski, Marian Tanofsky‐Kraff	1
2	Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report 2019 ·The Journal of Prevention of Alzheimer s Disease ·Randall J. Bateman, Kaj Blennow, Rachelle S. Doody, Suzanne Hendrix, Simon Lovestone, Stephen Salloway, Rachel Schindler, Michael W. Weiner, Henrik Zetterberg, Paul Aisen, Bruno Vellas	42
3	Considerations for the assessment of suicidal ideation and behavior in older adults with cognitive decline and dementia 2016 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Larry Alphs, H. Robert Brashear, Phillip Chappell, Yeates Conwell, Sarah Dubrava, Ni A. Khin, Nicholas Kozauer, Dean M. Hartley, David S. Miller, Rachel Schindler, Eric Siemers, Michelle Stewart, Kristine Yaffe	17
4	Suicidal ideation and behavior assessment in dementia studies: An Internet survey 2016 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·Phillip Chappell, Sarah Dubrava, Michelle Stewart, Dean M. Hartley, Larry Alphs, H. Robert Brashear, Yeates Conwell, David S. Miller, Rachel Schindler, Eric Siemers, Kristine Yaffe	4
5	Disruption of cholinergic neurotransmission exacerbates Aβ-related cognitive impairment in preclinical Alzheimer's disease 2015 ·Neurobiology of Aging ·Yen Ying Lim, Paul Maruff, Rachel Schindler, Brian R. Ott, Stephen Salloway, Don C. Yoo, Richard B. Noto, Cláudia Y. Santos, Peter J. Snyder	62
6	Revisiting the framework of the National Institute on Aging‐Alzheimer's Association diagnostic criteria 2013 ·Alzheimer s & Dementia ·María C. Carrillo, Robert A. Dean, (unknown), David S. Miller, Robert Berman, Zaven S. Khachaturian, Lisa J. Bain, Rachel Schindler, David S. Knopman	45
7	Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup breakdown → 2011 ·Alzheimer s & Dementia ·Reisa A. Sperling, Clifford R. Jack, Sandra E. Black, Matthew P. Frosch, Steven M. Greenberg, Bradley T. Hyman, Philip Scheltens, María C. Carrillo, William Thies, Martin M. Bednar, Ronald S. Black, H. Robert Brashear, Michael Grundman, Eric Siemers, Howard Feldman, Rachel Schindler	554
8	Study design considerations: Conducting global clinical trials in early Alzheimer's disease 2010 ·The journal of nutrition health & aging ·Rachel Schindler	10
9	Effects of donepezil on activities of daily living: integrated analysis of patient data from studies in mild, moderate and severe Alzheimer's disease 2010 ·International Psychogeriatrics ·Serge Gauthier, Oscar L. López, Gunhild Waldemar, Roy Jones, Jeffrey L. Cummings, Richard Zhang, Rachel Schindler, Elias Schwam	29
10	Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer’s Disease 2009 ·Dementia and Geriatric Cognitive Disorders ·David Wilkinson, Rachel Schindler, Elias Schwam, Gunhild Waldemar, Roy Jones, Serge Gauthier, Oscar L. López, Jeffrey L. Cummings, Yikang Xu, Howard Feldman	39
11	Rates of Cognitive Change in Alzheimer Disease 2009 ·Alzheimer Disease & Associated Disorders ·Roy Jones, Elias Schwam, David Wilkinson, Gunhild Waldemar, Howard Feldman, Richard Zhang, Kenneth S. Albert, Rachel Schindler	20
12	P1‐260: Disease progression of cognitive impairment in Alzheimer's disease: A model‐based approach 2009 ·Alzheimer s & Dementia ·Susan Willavize, Miia Kivipelto, David L. Sparks, Roy Jones, Andrei Breazna, David A. DeMicco, Judith Hey‐Hadavi, Rachel Schindler, Brian Corrigan	1
13	The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): Design and baseline characteristics 2008 ·Alzheimer s & Dementia ·Roy Jones, Miia Kivipelto, Howard Feldman, (unknown), Rachelle S. Doody, David D. Waters, Judith Hey‐Hadavi, Andrei Breazna, Rachel Schindler, (unknown), (unknown)	53
14	Otępienie naczyniopochodne i mieszane: znaczenie wczesnego leczenia farmakologicznego 2008 ·Via Medica Journals ·Rachel Schindler	1
15	Safety and Tolerability of Donepezil at Doses up to 20 mg/day 2008 ·Drugs & Aging ·Rachelle S. Doody, Jody Corey‐Bloom, Richard Zhang, Honglan Li, John R. Ieni, Rachel Schindler	36
16	3-Year Study of Donepezil Therapy in Alzheimer’s Disease: Effects of Early and Continuous Therapy 2006 ·Dementia and Geriatric Cognitive Disorders ·Bengt Winblad, Anders Wimo, Knut Engedal, Hilkka Soininen, Frans R.J. Verhey, Gunhild Waldemar, A.-L. Wetterholm, Anders Haglund, (unknown), Rachel Schindler	137
17	Dementia with cerebrovascular disease: the benefits of early treatment 2005 ·European Journal of Neurology ·Rachel Schindler	15
18	Donepezil in Vascular Dementia: Combined Analysis of Two Large-Scale Clinical Trials 2005 ·Dementia and Geriatric Cognitive Disorders ·Gustavo C. Román, David Wilkinson, Rachelle S. Doody, Sandra E. Black, Stephen Salloway, Rachel Schindler	76
19	Associative Visual Agnosia and Alexia Without Prosopagnosia 1994 ·Cortex ·Todd E. Feinberg, Rachel Schindler, (unknown), (unknown), Martha J. Farah	71
20	Anosognosia and Visuoverbal Confabulation 1994 ·Archives of Neurology ·Todd E. Feinberg, David M. Roane, (unknown), Rachel Schindler, (unknown)	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact